deltatrials
Completed NCT00005442

Re-evaluating Triglycerides in Coronary Heart Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Updated 6 times since 2017 Last updated: Mar 15, 2016 Started: Jun 30, 1994 Completion: May 31, 2000

This observational or N/A phase trial investigates Cardiovascular Diseases and Coronary Disease and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 6 recorded versions since 1994 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

Show 1 earlier version
  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Jun 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.